Aimei Health Technology Co., Ltd Ordinary Share (AFJK) is a publicly traded Financial Services sector company. As of May 21, 2026, AFJK trades at $40.77 with a market cap of $131.72M and a P/E ratio of 0.00. AFJK moved +13.03% today. Year to date, AFJK is -4.17%; over the trailing twelve months it is +296.33%. Its 52-week range spans $6.75 to $130.37. Rallies surfaces AFJK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aimei Health Faces 60-Day Nasdaq Deadline After Late Q1 10-Q Filing Notice: Aimei Health Technology Co. received a Nasdaq notice citing noncompliance for missing its May 15 deadline to file the Form 10-Q for quarter ended March 31, 2026. The company has 60 days to file the report or submit a compliance plan or face potential delisting under Listing Rule 5250(c)(1).
| Metric | Value |
|---|---|
| Price | $40.77 |
| Market Cap | $131.72M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.37 |
| 52-Week Low | $6.75 |
| Volume | 10.26K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $1.06M |
| Gross Margin | 0.00% |
AFJK analyst coverage data. Average price target: $0.00.